Osteoarthritis is a chronic, progressive degenerative joint disease, which is characterized by gradual destruction of the articular cartilage, hypertrophy of the bone margins, and a series of biochemical and morphological changes in the synovial membrane and joint capsule. This results in pain and loss of movement. Medicines for Osteoarthritis Pain are available as pills, syrups, creams or lotions, or they are injected into a joint. This report mainly studies the Drugs for Osteoarthritis market, the key role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.
Market Analysis and Insights: Global and United States Osteoarthritis Medications Market
This report focuses on global and United States Osteoarthritis Medications market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Osteoarthritis Medications market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, NSAIDs accounting for % of the Osteoarthritis Medications global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Hospital Pharmacies was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Osteoarthritis Medications market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Osteoarthritis Medications Scope and Market Size
Osteoarthritis Medications market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Osteoarthritis Medications market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Osteoarthritis Medications market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
NSAIDs
Corticosteroids
Hyaluronic Acid Injection
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Pfizer
Johnson & Johnson
GlaxoSmithKline
Novartis
Bayer
Eli Lilly
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
Flexion Therapeutics
Anika Therapeutics
Market Analysis and Insights: Global and United States Osteoarthritis Medications Market
This report focuses on global and United States Osteoarthritis Medications market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Osteoarthritis Medications market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, NSAIDs accounting for % of the Osteoarthritis Medications global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Hospital Pharmacies was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Osteoarthritis Medications market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Osteoarthritis Medications Scope and Market Size
Osteoarthritis Medications market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Osteoarthritis Medications market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Osteoarthritis Medications market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
NSAIDs
Corticosteroids
Hyaluronic Acid Injection
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Pfizer
Johnson & Johnson
GlaxoSmithKline
Novartis
Bayer
Eli Lilly
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
Flexion Therapeutics
Anika Therapeutics
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects...
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects including drivers, restraints...